Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes
Gina Ryan, Tim A Briscoe, Lynette JobeCollege of Pharmacy and Health Sciences, Mercer University, Atlanta, Georgia, USAAbstract: Pramlintide (Symlin®), a synthetic analog of a neurohormone amylin, was approved by the US Food and Drug Administration for use along with premeal insulin in patie...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Knjiga |
| Izdano: |
Dove Medical Press,
2008-10-01T00:00:00Z.
|
| Teme: | |
| Online pristup: | Connect to this object online. |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Internet
Connect to this object online.3rd Floor Main Library
| Signatura: |
A1234.567 |
|---|---|
| Primjerak 1 | Dostupno |